|
|
 |
| Авторизация |
|
|
|
| Поиск по указателям |
|
|
|
|
|
|
|
 |
|
|
|
| Hermanson G.T. — Bioconjugate Techniques |
|
|
|
| Предметный указатель |
Alkyl halide, reactions of 147 158
Alkyl halide, reactions with pyrimidines 44
Alkylation 8
Alkylation by maleimides 95
Alkylation of amines 137
Alkylation of hydroxyls 29
Alkylation of nucleic acids 44
Alkylation of purines 48
Alkylation of pyrimidines 44
Alkylation of sulfhydryls 146
Alkylation with iodoacetate 98
Alkylation, reductive 160 185;
Allen 537
Allergic reactions, to immunotoxins 496
Allfrey 209
Allison 131 428 533 549
Allmer 223
Allophycocyanin 363
Allophycocyanin, tandem conjugate with B-phycoerythrin 364
Alum 425
Alvear 88
Alving 428 533 549
Amadori rearrangement 37 141
AMBH 252
AMBH, modification of oxidized carbohydrates 71
AMBH, use for thiolation 71
AMCA 331 332 488
AMCA, as photoreactive group in SAED 268
AMCA, comparison to fluorescein 332
AMCA, general description and use 332
AMCA, group in sulfo-SAMCA 272
AMCA, hydrazide derivative of 339
AMCA, labeling of avidin with 587
AMCA, reaction with EDC 332
AMCA, sulfhydryl-reactive derivatives 335
AMCA, within SAED 299
AMCA-HPDP 651
AMCA-HPDP, general properties and use 335
AMCA-HPDP, protein modification protocol 337
AMCA-hydrazide, general properties and use 339
AMCA-hydrazide, modification of antibodies 341
AMCA-NHS 587
AMCA-NHS, general properties and use 333
AMCA-NHS, labeling of avidin with 587
AMCA-NHS, photodecomposition of 333
AMCA-NHS, protein labeling protocol 335
AMCA-sulfo-NHS, general properties and use 333
Amidine 144 203 204 205 206 207 562
Amine boranes 142
Amines,  -amines of biocytin 392
Amines, -amines, pKa 7
Amines,  -amines 7 91
Amines, acylation with citraconic anhydride 96
Amines, acylation with glutaric anhydride 94
Amines, acylation with maleic anhydride 94
Amines, acylation with succinic anhydride 91
Amines, blocking of 125 126
Amines, blocking with acetic anhydride 127
Amines, blocking with sulfo-NHS-acetate 127
Amines, coupling by reductive animation 185
Amines, coupling using CMC 177
Amines, coupling using DCC 178
Amines, coupling using DIG 181
Amines, coupling using EDC 170
Amines, coupling with carbodiimides 144
Amines, coupling with Woodward's reagent K 181
Amines, detection of 112
Amines, detection with TNBS 112
Amines, detection, using OPA 80 113
Amines, for blocking aldehydes 135
Amines, introduction of 100
Amines, Mannich reaction with formaldehyde 216
Amines, modification with glutaraldehyde 118
Amines, modification with SFB 117
Amines, modification with SFPA 117
Amines, reaction of 137
Amines, reaction with acyl azides 139
Amines, reaction with aldehydes 141
Amines, reaction with alkyl halides 226
Amines, reaction with ANB-NOS 263
Amines, reaction with anhydrides 146
Amines, reaction with aryl halides 143 149
Amines, reaction with carbodiimides 154
Amines, reaction with chloroacetic acid 100
Amines, reaction with dehydroazepines 254
Amines, reaction with diazopyruvates 272
Amines, reaction with difluorobenzene derivatives 211
Amines, reaction with epoxides 142 155 220
Amines, reaction with formaldehyde 216
Amines, reaction with GDI-activated hydroxyls 155
Amines, reaction with glutaraldehyde 218
Amines, reaction with GMBS 244
Amines, reaction with haloacetyl compounds 147
Amines, reaction with HSAB 260
Amines, reaction with imidoesters 143 203
Amines, reaction with isocyanates 138
Amines, reaction with isothiocyanates 138
Amines, reaction with maleimides 148
Amines, reaction with MBS 237
Amines, reaction with NHS esters 139 191
Amines, reaction with NHS-ASA 256
Amines, reaction with NHS-chloroformate activated hydroxyls 156
Amines, reaction with NPIA 248
Amines, reaction with p-nitrophenyl diazopyruvate 272
Amines, reaction with p-nitrophenyl esters 248
Amines, reaction with PNP-DTP 274
Amines, reaction with SADP 265
Amines, reaction with SAED 268
Amines, reaction with SAND 264
Amines, reaction with SANPAH 261
Amines, reaction with SASD 257
Amines, reaction with SIAB 239
Amines, reaction with SIAC 247
Amines, reaction with SIAX 245
Amines, reaction with SMCC 235
Amines, reaction with SMPB 242
Amines, reaction with SMPT 233
Amines, reaction with SPDP 231
Amines, reaction with sulfo-SAMCA 272
Amines, reaction with sulfo-SAPB 266
Amines, reaction with sulfo-SBED 289
Amines, reaction with sulfonyl chlorides 140
Amines, reversible blocking with maleic anhydride 129
Amines, Schiff base formation 160
Amino acid 5
Amino acid analysis 308
Amino acid, aliphatic 5
Amino acid, aromatic, hydrophobic 6
Amino acid, detection with OPA 113
Amino acid, ionizable 6
Amino acid, polar, hydrophilic 6
Aminoacyl-transferase II see “EF2”
Aminoalkylation 101
Aminoethyl-8 105
Aminoethyl-8, general description and use 104
Aminoethylation 104
Aminoethylation of cBSA 423
Aminoethylthioacetyl spacer 542
Ammonia 32 148 216 450
Ammonia in Mannich reaction 161
Ammonia in reductive amination 160
Ammonia, coupling to aldehydes 109
Ammonium chloride 305 320
Ammonium ion, reaction with an epoxide 142
AMP, immobilized 647
Amphipathic 533 536 548
Amphipathic chelating molecules 368
Amphiphilic 528 606
Amylopectin 620
ANB-NOS, general description and use 263
| Anderson 39 133 153 183 454 615
Ando 308 309
Angiotensin II 195
Anhydrides 90 128 129
Anhydrides of DTPA 365 492
Anhydrides of SAMSA 70
Anhydrides, as blocking agents 126
Anhydrides, formation using DCC 180
Anhydrides, glutaric anhydride 94
Anhydrides, maleic anhydride 94
Anhydrides, modification of amines 90
Anhydrides, modification of PEG with 609
Anhydrides, reactions of 145
Anhydrides, succinic 91
Aniline 32
Aniline, derivatives 402
Anjaneyulu 173 176 190 438
Annunziato 138 158 159
Anterograde tracing studies 375 620
Antibodies 22 78 102 125 223 224 236 241 252 258
Antibodies as a targeting component 630
Antibodies at sulfhydryl sites 384
Antibodies,  -galactosidase conjugate 634
Antibodies, activation of, with PDTP 513
Antibodies, activation of, with periodate 475 477
Antibodies, activation of, with SMCC 501 521
Antibodies, activation of, with SPDP 504 508 509
Antibodies, activation of, with sulfo-SMCC 461 520
Antibodies, biotinylated 363 372 476 492 572 574 584 638
Antibodies, biotinylation of 488
Antibodies, carrier-specific 426
Antibodies, class 457
Antibodies, conjugation of, controlling the size of conjugates 473
Antibodies, conjugation of, dextran conjugate with toxins 494
Antibodies, conjugation of, through carbohydrate regions 459
Antibodies, conjugation of, to liposomes 552
Antibodies, conjugation of, to liposomes, using NHS-palmitate 556
Antibodies, conjugation of, to toxins, using cystamine 515
Antibodies, conjugation of, to toxins, using SIAB 517
Antibodies, conjugation of, to toxins, using SMPT 511
Antibodies, conjugation of, to toxins, using via disulfide exchange 478 503
Antibodies, conjugation of, using antibody fragments 478
Antibodies, conjugation of, using glutaraldehyde 470
Antibodies, conjugation of, using reduced antibodies 463
Antibodies, conjugation of, with amine or hydrazide derivatives 476
Antibodies, conjugation of, with deglycosylated ricin A chains 501
Antibodies, conjugation of, with dextran 624
Antibodies, conjugation of, with enzymes 460
Antibodies, conjugation of, with glucose oxidase 635
Antibodies, conjugation of, with intact toxins 494 499 501
Antibodies, conjugation of, with lymphokines 494
Antibodies, conjugation of, with periodate-oxidized HRP 115
Antibodies, conjugation of, with phycobiliproteins 363
Antibodies, conjugation of, with ricin A chain using SMPT 511
Antibodies, conjugation of, with SMCC-activated enzymes 461
Antibodies, conjugation of, with toxins using oxidized dextran 494 527
Antibodies, cross-linking with DSP 193
Antibodies, cytotoxic complexes 494
Antibodies, detection using biotinylated immunoglobulin binding proteins 574
Antibodies, detection using protein A-gold 599
Antibodies, digestion with papain 480
Antibodies, digestion with pepsin 479
Antibodies, directed against the crossbridge 229
Antibodies, EDC conjugation to liposomes 559
Antibodies, effect of sodium cyanoborohydride 186
Antibodies, enzymatic digestion of 458
Antibodies, enzyme conjugates of 636
Antibodies, enzyme conjugation with DPDPB 210
Antibodies, fluorescein-labeled 304 588
Antibodies, fluorescently labeled 297 488
Antibodies, functioning as the B chain in immunotoxins 499
Antibodies, glucose oxidase conjugate 635
Antibodies, glycosylation sites 458
Antibodies, gold labeling of 600
Antibodies, gold-labeled 596
Antibodies, humanized mouse monoclonals 496
Antibodies, immobilization using the protein A/DMP method 206
Antibodies, immunotoxin conjugate design 499
Antibodies, labeling with AMCA-hydrazide 340
Antibodies, labeling with NHS-fluorescein 307
Antibodies, labeling with NHS-rhodamine 322
Antibodies, labeling with radionuclides 365 492
Antibodies, labeling with TRITC 320
Antibodies, liposome conjugate with 494 528
Antibodies, modification, conjugation of, and 456
Antibodies, modification, with  through sulf-hydryls 370
Antibodies, modification, with bifunctional chelating agents 365 492
Antibodies, modification, with biotin-HPDP 387
Antibodies, modification, with chelating polymer 366
Antibodies, modification, with DFA 370
Antibodies, modification, with DTPA 366
Antibodies, modification, with DTTA 369
Antibodies, modification, with fluorescein-5-thiosemicar-bazide 313
Antibodies, modification, with NHS-iminobiotin 380 381
Antibodies, modification, with NHS-LC-biotin 379 492
Antibodies, modification, with sulfo-NHS-SS-biotin 382
Antibodies, monoclonal 365 494
Antibodies, optimal fluorophore incorporation 489
Antibodies, partial reduction using DTT 522 523
Antibodies, periodate oxidation of 475 477
Antibodies, pI of 595
Antibodies, preserving antigen binding sites 21 228
Antibodies, primary 489
Antibodies, production of 419
Antibodies, radiolabeled 298 365 460
Antibodies, radiolabeling of 488 490
Antibodies, reactions with sodium cyanoborohydride 142
Antibodies, recombinant 460 496
Antibodies, reduction of disulfides 76
Antibodies, reduction of disulfides, using DTT 523
Antibodies, reduction of disulfides, with 2-mercaptoethyl-amine 82 336
Antibodies, reductive amination with enzymes 476
Antibodies, removal of unconjugated enzyme 483
Antibodies, role of in immunotoxins 499
Antibodies, SATA-modified 469
Antibodies, secondary 489
Antibodies, single-chain 496
Antibodies, site-directed conjugation of 459
Antibodies, SMCC-activated 501
Antibodies, structure of 457
Antibodies, thiolation of 461
Antibodies, thiolation of, at carbohydrate residues 371
Antibodies, thiolation of, with 2-iminothiolane 465
Antibodies, thiolation of, with PDPH 371
Antibodies, thiolation of, with SATA 61 467
Antibodies, thiolation of, with SPDP 504 508 518
Antibody immunoconjugates for cancer 494
Antibody response against a cross-linker 429
Antibody response, to liposome immunogens 549
Antibody response, toward cross-linker 441
Antibody response, toward polymerized haptens 429
Antibody-deglycosylated ricin A chain, largescale preparation of 511
Antibody-enzyme conjugation 120 188 220 235 236 239 241
Antibody-enzyme conjugation, purification by immunoaffinity chromatography 485
Antibody-enzyme conjugation, removal of unconjugated enzyme 484
Antibody-enzyme conjugation, using metal chelate affinity chromatography 486
Antibody-enzyme conjugation, using NHS ester-maleimide cross-linkers 461
Antibody-liposome conjugates 552
Antibody-toxin conjugates, formation via pyridyl disulfide cross-linkers 503
Antigen 387 488 493 554
Antigen binding sites 78 82 249 370 371 458 465 476 482 483 485 490 496 502 636
Antigen binding sites, blocking of 456 459
Antigen presenting cells 423
Antigen specificity 365
Antigen, definition of 419
Antigen, detection using biotinylated antibodies 584
Antigen, detection using colloidal gold labeling 593
Antigen, encapsulation in liposomes 550
Antigen, immobilized 456 484
Antigen, localized using avidin-biotin interaction 574
|
|
|
| Реклама |
|
|
|
|
|
О проекте